Navitas Life Sciences

Navitas Life Sciences is a mid-sized, knowledge-driven CRO positioned as a 'Major Contender' in clinical data management. It offers end-to-end services across the drug development lifecycle, from advisory and clinical development to post-marketing surveillance, supported by a global footprint with eight offices in five countries. The company differentiates itself through its proprietary industry networks, technology and data modernization focus, and deep therapeutic expertise across 20+ areas including oncology, neurology, and cell and gene therapy. With strong client re-engagement rates and a track record of hundreds of regulatory submissions, Navitas is a tech-enabled service provider in the competitive CRO landscape.

Integrated technology and data modernization platform supporting clinical operations, data management, pharmacovigilance, regulatory submissions, and analytics. Includes tools for decentralized clinical trials, real-world evidence generation, and proprietary data/analytics systems like 'OneClinical Analytics'.

Operates in the highly competitive global CRO market, competing against large players (e.g., IQVIA, ICON, Labcorp) and numerous mid-sized and niche CROs. Differentiates through a tech-enabled, knowledge-driven model with proprietary industry networks, a focus on bespoke solutions for biotech/pharma, and deep therapeutic expertise. Positioned as a 'Major Contender' in Clinical Data Management.